-
Goldman Sachs Upgrades Walmart To Buy, Credits Tax Reform
Thursday, January 18, 2018 - 9:57am | 349Read More...Shares of Wal-Mart Stores Inc (NYSE: WMT) have gained more than 50 percent over the past year as the company's various initiatives gained momentum. But one notable firm kept a neutral stance on the stock until now. The Analyst Goldman Sachs' Matthew Fassler upgraded Walmart's stock...
-
Welcome BlackRock, Goodbye Invesco: Goldman Adjusts Its Americas Conviction List Roster
Thursday, September 28, 2017 - 2:03pm | 490Read More...Amid the changing trends in the asset management space, Goldman Sachs made some adjustments to its Americas Conviction List. The firm upgraded BlackRock, Inc. (NYSE: BLK) and T. Rowe Price Group Inc (NASDAQ: TROW), while it downgraded shares of Invesco Ltd. (NYSE: IVZ). The firm made a...
-
State Street Added To Goldman's Conviction List
Wednesday, June 28, 2017 - 10:32am | 355Read More...State Street Corp (NYSE: STT), a provider of a range of financial products and services to investors, was added to Goldman Sachs' "Americas Conviction List" amid three compelling upcoming catalysts. Goldman Sachs' Alexander Blostein also maintains a Buy rating on State Street's stock with a price...
-
An Unlikely Candidate For Goldman's 'Conviction Buy' List: Cedar Fair
Monday, June 19, 2017 - 10:44am | 543Read More...Goldman Sachs analyst Christopher Prykull sees several positive catalysts for Cedar Fair, L.P. (NYSE: FUN), causing him to add the entertainment company to Americas Conviction List. Prykull is eyeing a 15-percent return and left his 12-month price target at $81. “We believe FUN is uniquely...
-
Select Oil, Gas Names Boosted By Goldman's Hess Call
Wednesday, February 10, 2016 - 10:26am | 249Read More...Shares of Hess Corp. (NYSE: HES) were trading higher by nearly 2 percent ahead of Wednesday's market open after analysts at Goldman Sachs upgraded their stock rating to Buy from Neutral. Hess was also added to Goldman Sach's Americas Conviction List given an estimated 52 percent total...
-
Clovis Oncology, FibroGen Are Key Biotech Names For Goldman Sachs
Monday, July 20, 2015 - 7:56am | 425Read More...In a report published Sunday, Goldman Sachs analyst Terence Flynn discussed the biotech space, noting the sector's most commonly referenced index, the NASDAQ Biotechnology (INDEX: NBI) gained 28 percent year-to-date, drastically outperforming the S&P 500's 2 percent return over the...
-
Why Goldman Removed Starbucks From Its 'Conviction List'
Wednesday, July 1, 2015 - 1:20pm | 377Read More...In a report published Wednesday, Goldman Sachs analyst Karen Holthouse removed shares of Starbucks Corporation (NASDAQ: SBUX) from its ‘Americas Conviction List' but retained a Buy rating with a $57 price target, noting that there are other stocks with greater upside potential. Since...
